| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |